Search

everythinglearnresearchcommunity

for

Search:↓

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

A rare case linked complete hair loss to both pancreas and gallbladder cancer.

Pediatricians should advise sexually active teens on safe sex and STD prevention, and discuss contraceptive options and their side effects.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

COVID-19 infection or vaccination may trigger lichen planus.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Women with congenital adrenal hyperplasia showed no prostatic growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

A rare ovarian tumor caused early puberty in a 3-year-old girl.

Chemotherapy reduces splenic melanin in mice.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.